News

Rare kidney cancer resists immune therapies due to lack of active T-cells
Cancer-fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal ...
Fierce Biotech8d
ProKidney’s CKD cell therapy scores win in one half of phase 2 trial, falls short on other
At one point, ProKidney had been running an international phase 3 trial, dubbed PROACT 2, of rilparencel alongside the ...
Mirage News13d
Breakthrough in Chromophobe Renal Cancer Treatment
Cancer fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal cell ...
Los Angeles Times1mon
Polycystic Kidney Disease: Causes, Treatments, and What’s Ahead
Over time these cysts can grow, replace normal kidney tissue and lead to end stage kidney disease ... (2025) looks at the primary cilium – a tiny antenna-like structure on kidney cells.
MedPage Today8mon
CAR T-Cell Therapy for Kidney Cancer Builds on Efficacy Record
LOUISVILLE, Ky. -- A CD70-targeted CAR T-cell therapy for advanced kidney cancer continued to show durable activity in treatment-refractory patients, according to updated results from a ...